<h3>Background and Aims</h3> There is a need to continuously search for potential biomarkers for early stroke diagnosis and prognostication, especially in low resource settings. This pilot study determined the relationship between admission serum NGAL, clinical severity and the short- term outcome of acute stroke. <h3>Methods</h3> The study was done at the University of Ilorin Teaching Hospital. Forty patients with clinical and radiological evidence of stroke were recruited between April and July 2021 and compared with equal number of apparently healthy stroke-free, age- and sex-matched controls. Blood sample collection for serum NGAL levels were taken within 72 hours of ictus. Stroke severity on admission was assessed using the National Institutes of Health Stroke Scale (NIHSS) while the functional outcome at one month was assessed using the Modified Rankin Scale (mRS). <h3>Results</h3> A total of 40 stroke subjects (23 males and 17 females) and 40 controls were enrolled into the study with mean age of 58.3 ± 13.5 and 58.3+ 11.3 years respectively. The mean values of NGAL for ischemic, hemorrhagic and controls were 22.8 ± 7.8, 18.9 ± 5.8 and 17.7 ± 7.5 (ng/ml) respectively, with a significant difference between ischaemic stroke subjects and controls (p =0.019). No correlation was found between NGAL levels and clinical severity at admission (r= -0.018, p=0.912), functional outcome (r 0.240, p=0.136) and mortality (r= 0.188, p=0.245). <h3>Conclusion</h3> NGAL levels are elevated in stroke patients but its role in diagnosis and prognostication needs further study.
Read full abstract